logo

For the Inventor, By the Inventor

Newtown, PA, United States of America

Gerard J O'Malley

This inventor holds 30 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Hoechst Roussel Pharmaceuticals, Hoechst Marion Roussel, Aventis Pharmaceuticals Inc.. Active years: 1989-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerard J O'Malley. Retrieved from https://idiyas.com/inventor/gerard-j-o-malley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30

% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 6

Forward Citations = 160(Granted Patents)


Location History:

  • Newton, PA (US) (1989 - 2001)
  • Newtown, PA (US) (1991 - 2002)

Company Filing History:

goldMedal15 out of 539 
 
Hoechst Roussel Pharmaceuticals
 patents
silverMedal11 out of 236 
 
Hoechst Marion Roussel
 patents
bronzeMedal2 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
4. 2 out of 6,705 
 
Hoechst Aktiengesellschaft
 patents

Years Active: 1989-2002

Loading Chart...
Areas of Expertise:
Spiro Compounds
Oligonucleotide Analogs
Carbamoyloxylabdanes
Benzisoxazoles
Hydrazinocarbonyloxylabdanes
Cyclopent[b]indoles
Tetrahydrocyclopent[b]indoles
Amides
Ureas
Cardiac Failure
Intraocular Pressure
30 patents (USPTO):Explore Patents
1. 6479501 - Spiro[cyclopent[b]indole-piperidines] (2002-11-12),
2. 6229014 - Spiro[cyclopent[b]indole-piperidines] (2001-05-08),
3. 6156901 - Spiro[cyclopent[b]indole-piperidines] (2000-12-05),
4. 6046203 - Substituted 3-(aminoalklamino)-1,2-benzisoxazoles and related compounds (2000-04-04),
5. 6033909 - Oligonucleotide analogs, their preparation and use (2000-03-07),
6. 5986097 - Spiro[cyclopent[b]indole-piperidines] (1999-11-16),
7. 5925766 - Substituted 3-(aminoalkylamino)-1, 2-benzisoxazoles and related compounds (1999-07-20),
8. 5869520 - Carbamoyloxylabdanes (1999-02-09),
9. 5847167 - Carbamoyloxlabdanes (1998-12-08),
10. 5756754 - Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds (1998-05-26),
11. 5756743 - Spiro�cyclopent�b!indole-piperidines! (1998-05-26),
12. 5708007 - 2-(piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl) (1998-01-13),
13. 5646261 - 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, (1997-07-08),
14. 5646175 - Carbamoyloxylabdane compounds (1997-07-08),
15. 5580982 - Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds (1996-12-03),

Title: Inventor Gerard J O'Malley

Introduction: Gerard J O'Malley, a distinguished inventor hailing from Newtown, PA (US), has made significant contributions to the field of innovations with his groundbreaking ideas and inventions.

Latest Patents: Gerard J O'Malley holds several patents in various industries, including technology, healthcare, and consumer goods. His recent patents focus on improving efficiency in renewable energy systems and enhancing user experience in wearable technology.

Career Highlights: With a career spanning over two decades, Gerard J O'Malley has established himself as a visionary inventor known for his ability to transform creative concepts into tangible solutions. He has received numerous awards for his innovative work and has been recognized for his contributions to advancing technology.

Collaborations: Throughout his career, Gerard J O'Malley has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His collaborative efforts have resulted in successful products that have had a positive impact on various industries.

Conclusion: Gerard J O'Malley's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor. His dedication to pushing the boundaries of what is possible continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…